SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is driving intense market conversation due to a historic short squeeze fueled by highly concentrated ownership among two major hedge funds, which effectively control the majority of the float and have limited available shares for short covering. Community members are actively debating the sustainability of this parabolic move, with many highlighting extreme technical indicators, high volatility, and potential regulatory scrutiny, while retail traders remain split between chasing the momentum and betting on an inevitable correction.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on high volume as the community dismisses a recent short-seller report and reacts to a bullish interview with CFO Thomas Mika, who confirmed production orders and an active expansion of manufacturing capacity. Investors are actively discussing the company's progress from a speculative venture to a commercial supplier within the AI infrastructure ecosystem, with many highlighting potential supply-chain tailwinds and upcoming milestones as key drivers for sentiment.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to a significant analyst price target increase and ongoing community excitement surrounding its role in the AI infrastructure supercycle. Traders are closely monitoring the stock's momentum, with many debating whether the current rapid gains signal a sustained breakout or an overextended position prone to consolidation.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares is currently experiencing a massive short squeeze and extended rally, driven by intense investor enthusiasm for the AI sector and semiconductor earnings expectations. While some traders are riding the aggressive momentum to new highs, a significant portion of the community is debating whether this parabolic move represents a sustainable golden era for chips or an overextended bubble prone to a sharp, sentiment-driven reversal.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is trending as investors digest positive registrational data from its phase 2 trial for stiff person syndrome, which showed statistically significant clinical benefits and a potential pathway to FDA approval. Community discussion is heavily focused on the company's best-in-class pipeline, potential for a lucrative buyout, and the transformative impact of its CAR-T therapy, despite some lingering debates regarding trial safety observations and capital raise activities.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

The community surrounding $IMG is rallying behind the token's passive Solana rewards and deflationary mechanisms, framing it as a 'battle-tested' utility play that has survived significant market adversity. Investors are actively discussing the protocol's technological resilience and upcoming milestones, viewing current entry levels as a strategic opportunity to accumulate ahead of a potential supply shock.

OpenGradient

OpenGradient is attracting significant momentum as traders view it as an early-stage opportunity and the next potential breakout candidate following recent market runners. The community is actively discussing high-volume liquidity and the potential for increased public awareness as they coordinate efforts to boost the asset's visibility.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing a significant surge in momentum as the community focuses on a mix of major contract wins, strategic defense partnerships, and a heavily shorted float setting the stage for a potential squeeze. Investors are actively discussing the company's critical role in the supply chains of industry giants like SpaceX and Anduril, interpreting these developments as a long-term catalyst for growth.

Phathom Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel treatments for gastrointestinal diseases. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Florham Park, NJ.

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals is currently generating significant community buzz ahead of upcoming financial results, with investors closely watching the company's path to profitability and potential acquisition appeal as a takeover target. Conversations are centered on Voquezna's continued market adoption, favorable patent exclusivity, and a strategic pivot toward GI specialists, which many believe sets the stage for a strong long-term performance.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing significant momentum driven by investor enthusiasm for its gallium nitride power technology, which is increasingly viewed as a critical component for AI data center efficiency. While bulls point to high-profile industry partnerships and long-term demand for AI infrastructure, the stock remains a flashpoint for debate, as skeptics warn that current price action is fueled by sentiment and short-term speculative positioning rather than immediate earnings-based fundamentals.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BIIB Inks Deal to Acquire Rights to Felzartamab in China, Stock Up

Biogen gains after securing Greater China rights to felzartamab, giving it worldwide control as phase III studies advance in immune diseases.

Align Technology's Q1 Earnings on Deck: Here's What to Expect

ALGN's Q1 report looms with revenues seen rising 4.3% and EPS up 6.1%, as Invisalign demand and iTero adoption drive growth trends.

HSBC Predicts Biogen's Q1 Earnings (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB - Free Report) - Investment analysts at HSBC issued their Q1 2026 earnings per share estimates for shares of Biogen in a research note issued to investors on Friday, April...

Mirae Asset Global Investments Co. Ltd. Decreases Position in Biogen Inc. $BIIB

Mirae Asset Global Investments Co. Ltd. cut its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 47.6% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned...

Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Apellis Pharmaceuticals, Inc. (NasdaqGS: APLS...

Edwards Lifesciences' Q1 Earnings on Deck: Here's What to Expect

EW heads into Q1 earnings with TAVR strength, rising estimates and momentum in mitral and tricuspid therapies shaping expectations.

Buy 5 Non-Tech Wide Moat Stocks to Strengthen Your Portfolio

BIIB, LMT, NOC, MA and MTD are five non-tech wide moat picks as durable advantages, defense demand, and digital payments growth position these stocks for resilient returns.

Here are Monday's biggest analyst calls: Nvidia, Apple, Tesla, Microsoft, Amazon, Ulta Beauty, Okta, Biogen, Meta & more

Here are the biggest calls on Wall Street on Monday...

Zurcher Kantonalbank Zurich Cantonalbank Buys 104,038 Shares of Biogen Inc. $BIIB

Zurcher Kantonalbank Zurich Cantonalbank grew its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 29.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 452,442 shares of the biotechnology company's stock after pur...

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region

TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region TJ Biopharma Enters into Agreement with Biogen for Felzartamab Assets in the Greater China Region PR Newswire CAMBRIDGE, Mass. and HANGZHOU, China, April 20, 2026 With this transaction, Biogen now owns...

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

BIIB
Biogen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BIIB News

BIIBBiogen Inc